NCT01698684View on ClinicalTrials.gov

Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Erectile Dysfunction
Interventions
DRUG

Placebo

One dose 15 minutes before attempting intercourse

DRUG

Avanafil 100 mg

One dose 15 minutes before attempting intercourse

DRUG

Avanafil 200 mg

One dose 15 minutes before attempting intercourse

Trial Locations (3)

Unknown

Jupiter

Raleigh

Wilmington

All Listed Sponsors
lead

VIVUS LLC

INDUSTRY

NCT01698684 - Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction | Biotech Hunter | Biotech Hunter